Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon
Open Access
- 15 December 2009
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 2 (3) , 206-216
Abstract
For more than 20 years after the excitement engendered by their discovery in 1957 as antiviral agents, there were no significant clinical uses of interferons; however, following their cloning they have been employed as effective treatment for several viral, autoimmune, and neoplastic diseases.Keywords
This publication has 63 references indexed in Scilit:
- MicroRNA Expression, Survival, and Response to Interferon in Liver CancerNew England Journal of Medicine, 2009
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C InfectionNew England Journal of Medicine, 2009
- Retreating chronic hepatitis C with daily interferon alfacon‐1/ribavirin after nonresponse to pegylated interferon/ribavirinHepatology, 2009
- Mutations in the Hepatitis C Virus core Gene Are Associated with Advanced Liver Disease and Hepatocellular CarcinomaClinical Cancer Research, 2009
- Predicting response to hepatitis C therapyJournal of Clinical Investigation, 2008
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonNew England Journal of Medicine, 2008
- Hepatitis B Virus InfectionNew England Journal of Medicine, 2008
- Peginterferon and Ribavirin for Chronic Hepatitis CNew England Journal of Medicine, 2006
- Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replicationLiver International, 1984
- Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's LymphomaNew England Journal of Medicine, 1978